Growth hormone neurosecretory dysfunction. A treatable cause of short stature

Area of Science:

• Pediatric Endocrinology
• Growth Hormone Physiology
• Child Development

Background:

• Pulsatile growth hormone (GH) secretion is crucial for normal growth.
• Short stature in children can stem from various causes, including GH deficiency and dysfunction.
• Understanding GH secretory patterns is vital for accurate diagnosis and treatment.

Purpose of the Study:

• To investigate GH secretory abnormalities in short children with suspected GH neurosecretory dysfunction.
• To compare GH secretion patterns between children with GH neurosecretory dysfunction, GH deficiency, and normal controls.
• To evaluate the response to exogenous human GH therapy in children with GH neurosecretory dysfunction.

Main Methods:

• Assessed pulsatile GH secretion over 24 hours in short children meeting specific criteria for GH neurosecretory dysfunction.
• Compared GH secretion parameters with those of normal and GH-deficient children.
• Monitored growth velocity changes after one year of exogenous human GH replacement therapy.

Main Results:

• Children with GH neurosecretory dysfunction showed significantly decreased total GH secretion over 24 hours compared to controls.
• GH-deficient children also exhibited reduced total 24-hour GH secretion.
• GH neurosecretory dysfunction patients more than doubled their growth velocity after one year of human GH treatment.

Conclusions:

• GH neurosecretory dysfunction is characterized by abnormal pulsatile GH secretion patterns.
• There exists a spectrum of GH secretory abnormalities, ranging from absolute deficiency to intermittent irregularities.
• Exogenous human GH therapy is effective in improving growth velocity in children with GH neurosecretory dysfunction.